News articles

2021 interns create TheatreCapture

2021 interns create TheatreCapture

Our 2021 interns built TheatreCapture, a cheap and simple method of collecting information from operating theatres.   Our interns, Jacob, Laith, Louise, Alex, Jaskirat and Tom worked fantastically as a group for 8 weeks to create an innovative data collection...

read more
Updated version of Simulacrum released

Updated version of Simulacrum released

We are pleased to announce the release of an updated version of the Simulacrum containing two additional years of diagnostic data (2013 – 2017 diagnoses) and treatment follow up to March 2018. This new version of the Simulacrum contains almost twice as many synthetic...

read more
Running an intern scheme in a global pandemic

Running an intern scheme in a global pandemic

A different year This year's intern scheme at Health Data Insight was intended to be different but we obviously didn't intend to run it in a global pandemic. COVID-19 meant changes to the planning and running of the internship, and here we reflect on how it worked...

read more
HDI symposium, 2019

HDI symposium, 2019

In November 2019, we held our 4th annual symposium in Cambridge to share some of the work we’ve been doing this year.  Over 50 people attended the day, with friends and colleagues joining us from across Public Health England, AstraZeneca, IQVIA, and the NHS. The day...

read more
Blog: The IACR and NAACCR Conference, Vancouver 2019

Blog: The IACR and NAACCR Conference, Vancouver 2019

The joint International Association of Cancer Registries and North American Association of Central Cancer Registries conference 2019, Vancouver written by Cong Chen The IACR is an organisation based in France which coordinates cancer registration practices and rules...

read more
The Simulacrum is launched

The Simulacrum is launched

This new database revolutionises the way scientists and researchers investigating cancer analyse the disease. The Simulacrum, so called because it artificially simulates real data about cancer without any risk of individual patients being identified, is a breakthrough...

read more